首页>
外国专利>
Antibody specifically recognizing an epitope for switching to Th2 cell and a method for converting T cell to type 2 helper T cell using the same
Antibody specifically recognizing an epitope for switching to Th2 cell and a method for converting T cell to type 2 helper T cell using the same
展开▼
机译:特异性识别切换至Th2细胞的表位的抗体和使用该抗体的将T细胞转化为2型辅助T细胞的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a novel epitope to convert T cell to type 2 helper T (TH2) cell. Specifically, the present invention relates to an epitope constituting the 20th to 30th amino acids (SEQ ID No. 2) of extracellular domain (ECD) of activation-inducible tumor necrosis factor receptor (AITR), an antibody recognizing the epitope, a polynucleotide encoding the epitope, a polynucleotide encoding the antibody, an expression vector comprising the polynucleotide encoding the epitope or antibody, a transformant introduced with the vector, a composition comprising the antibody for converting T cell to TH2 cell and a method of conversion, a pharmaceutical composition comprising the antibody for preventing or treating autoimmune disease, and a method for treating autoimmune disease using the antibody.
展开▼
机译:本发明涉及将T细胞转化为2型辅助T(T Sub H> 2)细胞的新型表位。具体地,本发明涉及构成激活诱导性肿瘤的细胞外结构域(ECD)的第20个至第30个氨基酸(SEQ ID No.2)的表位。坏死因子受体(AITR),识别表位的抗体,编码表位的多核苷酸,编码抗体的多核苷酸,包含编码表位或抗体的多核苷酸的表达载体,随载体引入的转化体,包含用于T细胞转化为T H Sub> 2细胞的方法,转化方法,包含用于预防或治疗自身免疫性疾病的抗体的药物组合物以及使用该抗体治疗自身免疫性疾病的方法。
展开▼